Abstract
The present prospective study intends to evaluate health-related quality of life (HRQL) and cognitive functioning in adult patients with supratentorial World Health Organization (WHO) grade II glioma (LGG) prior to observation/therapy and to determine possible influences of tumor-related factors on these measures. Adult patients with biopsy-proven supratentorial LGG were considered eligible (study period 18 months). Besides detailed documentation of patient clinical status we evaluated HRQL using the Short Form-36 (SF-36) Health Survey and applied the Beck Depression Inventory. Furthermore, attention and verbal memory functions were tested. Data from matched healthy control populations served as reference, and T-values were compared using Mann–Whitney U tests. For correlation of scores the Pearson test was utilized. Thirty-three patients with median Karnofsky Performance Status (KPS) of 80 were evaluated. Selective and divided attention showed significant impairment (P < 0.005), while verbal memory functions were unaffected. HRQL evaluated by SF-36 Health Survey was significantly reduced predominantly in the psychological domains (P < 0.025 to P < 0.0005). Nine patients displayed mild to moderate depression. Duration of symptoms >20 weeks and presence of seizures negatively affected aspects of HRQL, while cognitive functions were not influenced. KPS <80 correlated significant only with reduced physical functioning (P < 0.002) and role functioning (P < 0.01) on the SF-36 Health Survey. While displaying good clinical status, patients with LGG showed significant impairment in aspects of attention and affections of HRQL already at time of diagnosis. These results suggest that these impairments originate from the tumor and/or potentially from confrontation with the diagnosis itself.
Similar content being viewed by others
References
McCormack BM, Miller DC, Budzilovich GN, Voorhees GJ, Ransohoff J (1992) Treatment and survival of low-grade astrocytoma in adults 1977–1988. Neurosugery 31:636–642
Kreth FW, Faist M, Roßner R, Volk B, Ostertag C (1997) Supratentorial World Health Organization Grade II astrocytomas and oligoastrocytomas: a new pattern of prognostic factors. Cancer 79(2):370–379
Piepmeier JM (2009) Current concepts in the evaluation and management of WHO grade II gliomas. J Neurooncol 92:253–259
Olson JD, Riedel E, DeAngelis LM (2000) Long-term outcome of low-grade oligodendroglioma and mixed gliomas. Neurology 54(7):1442–1448
Taphoorn MJ, Heimans JJ, Snoek FJ et al (1992) Assessment of quality of life in patients treated for low grade glioma: a preliminary report. J Neurol Neurosurg Psychiatry 55:372–376
Taphoorn M, Schiphorst A, Snoek F, Lindeboom J, Wolbers J, Karim A, Huijgens P, Heimans J (1994) Cognitive functions and quality of life in patients with low-grade gliomas: the impact of radiotherapy. Ann Neurol 36:48–54
Kiebert GM, Curran D, Aaronson NK, Bolla M, Menten J, Rutten EHJM, Nordman E, Silvestre ME, Pierart M, Karim ABMF on behalf of the EORTC Radiotherapy Co-operative Group (1998) Quality of life after radiation therapy of cerebral low-grade gliomas of the adult: results of a randomised phase III trial on dose response (EORTC Trial 22844). Eur J Cancer 34(12):1902–1909
Klein M, Heimans J, Aaronson N, van der Ploeg H, Grit J, Muller M, Postma T, Mooij J, Boerman R, Beute G, Ossenkoppele G, van Imhoff G, Dekker A, Jolles J, Slotman B, Struikmans H, Taphoorn M (2002) Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study. Lancet 360:1361–1368
Correa DD, DeAngelis LM, Shi W, Thaler HT, Lin M, Abrey LE (2007) Cognitive functions in low-grade gliomas: disease and treatment effects. J Neurooncol 81(2):175–184
Correa DD, Shi W, Thaler HT, Cheung AM, DeAngelis LM, Abrey LE (2008) Longitudinal cognitive follow-up in low grade gliomas. J Neurooncol 86(3):321–327
Karnofsky DA, Burchenal JH (1949) The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod CM (ed) Evaluation of chemotherapeutic agents. Columbia University Press, New York, pp 191–205
Kleinhues P, Cavenee WK (eds) (2000) World Health Organisation of tumours. Pathology and genetics of tumours of the nervous system. IARC Press, Lyon, France
Zimmermann P, Fimm B (1993) Testbatterie zur Aufmerksamkeitsprüfung (TAP) Version 1.02. Handbuch Psytest, Freiburg, Germany
Ilmberger J (1988) Münchner Verbaler Gedächtnistest. Institut für Medizinische Psychologie, Universität München. München, Germany
Delis DC, Kramer JH, Kaplan E, Ober BA (1987) California verbal learning test. Psychological Corporation, San Antonio, TX
Bullinger M (1995) German translation and psychometric testing of the SF–36 health survey: prelininary results from the IQOLA project. International auality of life assesment. Soc Sci Med 41(10):1359–1366
Taphoorn MJB, Claassens L, Aaronson NK, Coens C, Mauer M, Osoba D, Stupp R, Mirimanoff RO, van den Bent MJ, Bottomley A, EORTC Quality of Life Group, Brain Cancer, NCIC and Radiotherapy Groups (2010) An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients. Eur J Cancer 46(6):1033–1040
Beck A, Steer R, Hautzinger M (1995) Beck-Depressions-Inventar (BDI): Testhandbuch. Huber, Bern, Göttingen, Toronto, Seattle
Klein M, Engelberts NHJ, Ploeg HM, Kesteleijn DGA, Aaronson NK, Taphoorn MJB, Baaijen H, Vandertop WP, Muller M, Postma TJ, Heilmanns JJ (2003) Epilepsy in low grade gliomas: the impact on cognitive functioning and quality of life. Ann Neurol 54:514–520
Reijneveld J, Sitskoorn M, Klein M, Nuyen J, Taphoorn M (2001) Cognitive status and quality of life in patients with suspected versus proven low-grade gliomas. Neurology 56:618–623
Taphoorn MJB, Klein M (2004) Cognitive deficits in adult patients with brain tumors. Lancet Neurol 3:159–168
Bjorklund DF, Kipp K (2002) Social cognition, inhibition, and theory of mind: the evolution of human intelligence. In: Sternberg RJ, Kaufman JC (eds) The evolution of intelligence. LEA, Mahwah, NJ
Douw L, Klein M, Fagel SS, van den Heuvel J, Taphoorn MJ, Aaronson NK, Postma TJ, Vandertop WP, Mooij JJ, Boerman RH, Beute GN, Sluimer JD, Slotman BJ, Reijneveld JC, Heimans JJ (2009) Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up. Lancet Neurol 8(9):810–818
Detmar SB, Aaronson NK, Wever LD, Muller M, Schornagel JH (2000) How are you feeling? Who wants to know? Patients’ and oncologists’ preference for discussing health-related quality of life issues. J Clin Oncol 18:3295–3301
Heimans JJ, Taphoorn MJB (2000) Impact of brain tumour treatment on quality of life. J Neurol 249:955–960
Gehring K, Sitskoorn MM, Gundy CM, Sikkes SA, Klein M, Postma TJ, van den Bent MJ, Beute GN, Enting RH, Kappelle AC, Boogerd W, Veninga T, Twijnstra A, Boerman DH, Taphoorn MJ, Aaronson NK (2008) Cognitive rehabilitation in patients with gliomas: a randomized, controlled trial. J Clin Oncol 27:3712–3722
Author information
Authors and Affiliations
Corresponding author
Additional information
Authors Maximilian I. Ruge and Josef Ilmberger contributed equally to this manuscript.
Rights and permissions
About this article
Cite this article
Ruge, M.I., Ilmberger, J., Tonn, JC. et al. Health-related quality of life and cognitive functioning in adult patients with supratentorial WHO grade II glioma: status prior to therapy. J Neurooncol 103, 129–136 (2011). https://doi.org/10.1007/s11060-010-0364-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-010-0364-9